Navigation Links
Dendreon Reports First Quarter 2009 Financial Results
Date:5/6/2009

====== ====== Shares used in computation of basic and diluted net loss ------ ------ per share 95,767 83,313 ====== ====== March 31, December 31, 2009 2008 ---- ---- Balance Sheet Data: Cash and cash equivalents $59,699 $59,523 Short-term investments 29,981 45,638 Long-term investments 1,519 3,386 Total assets 130,074 147,204 Warrant liability 11,811 14,190 Convertible senior subordinated notes 85,250 85,250 Total stockholders' equity 13,380 27,006


'/>"/>
SOURCE Dendreon Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related biology technology :

1. Dendreon Announces Data Presentations and Webcast at AUA Annual Meeting
2. Dendreon Announces Data on PROVENGE Potency and Long-Term Immune Responses in Androgen-Dependent Prostate Cancer
3. Dendreon Reports Fourth Quarter and 2008 Year End Financial Results
4. Dendreon Announces Webcast Presentation at Eleventh Annual BIO CEO & Investor Conference
5. Dendreon Announces Webcast Presentation at 27th Annual J.P. Morgan Healthcare Conference
6. Dendreon Reports Third Quarter 2008 Financial Results
7. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
8. Dendreon Presents Preclinical Data Validating Anti-Tumor Activity of D-3263, a Trp-p8 Agonist
9. Dendreon Announces Webcast Presentation at UBS Global Life Sciences Conference
10. Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
11. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... ... July 29, 2015 , ... G-CON ... the launch of their 2nd generation cell therapy POD® design. The 2nd generation ... it also represents a new POD® design. , “G-CON first offered our ...
(Date:7/29/2015)... CHICAGO , July 29, 2015  AmnioChor Inc., ... cell technology, is very pleased to announce that the ... has agreed to invest in their seed round ... OmniBank placental tissue storage capabilities. AmnioChor,s ... placenta, and the human stem cells living within those ...
(Date:7/29/2015)... 2015  Indivior PLC (LON: INDV) today announced that ... was accepted and received Priority Review by the U.S. ... opioid overdose. This naloxone nasal spray comes as a ... absorption into the nasal mucosa. 1 The device ... may be better equipped to help an opioid overdose ...
(Date:7/29/2015)... July 29, 2015 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: ... has selected an optimized Erk inhibitor molecule for ... development of a new class of potential cancer ... a prime target for therapeutic intervention in cancer. ... survival benefits for B-Raf and Mek inhibitors. Erk ...
Breaking Biology Technology:G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 2G-CON Manufacturing Launches Their 2nd Generation Cell Therapy Cleanroom POD® 3The Musculoskeletal Transplant Foundation Agrees to Invest in AmnioChor 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 2Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 3Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 4Indivior PLC Announces FDA Acceptance of Naloxone Nasal Spray New Drug Application With Priority Review 5Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 2Aeterna Zentaris Announces Optimized Erk Inhibitor Compounds For Further Development 3
... has announced that Berbee Information Networks , which is ... $250,000 in state Technology Zone tax credits. , ,Berbee, founded ... building and a 51,500-square-foot data center in the New Venture ... , ,The project is expected to cost $1.9 million and ...
... - Merge Technologies reported a net loss of ... 2007, more than double the net loss of $4.9 million, or ... the first quarter loss was well below the $27.0 million, or ... 2006, it signaled continuing difficulties for a company that is trying ...
... is opening up. Tens of millions of people adept at ... are already in, the workforce - bringing expectations, skills and ... that can inspire the passion and harness the skills of ... Here's why. , ,Until recently, workers of all levels ...
Cached Biology Technology:Media-savvy workers: New front in the War for Talent 2Media-savvy workers: New front in the War for Talent 3Media-savvy workers: New front in the War for Talent 4Media-savvy workers: New front in the War for Talent 5
(Date:7/8/2015)... DIEGO , July 8, 2015  Trovagene, ... cell-free molecular diagnostics, today announced the launch of ... the Company,s Precision Cancer Monitoring℠ (PCM) technology for ... receiving one or a combination of the novel ... Opdivo® (nivolumab), a PD-1 inhibitor. The 50-patient study ...
(Date:7/7/2015)... Conn. , July 7, 2015 NXT-ID, Inc. (NASDAQ: ... focused on the growing mobile commerce market announces a revised version ... this week. The commercial will air on CNBC in ... Los Angeles and San Francisco ... The commercial focuses on Wocket,s ability to replace all the cards ...
(Date:6/30/2015)... -- To bolster its efforts and commitment to fighting cyber ... addition of two new team members. ... David Raviv will act as head of strategic alliances. ... providing the most secure solutions for the enterprise market. ... Technologies, a provider of security and management products, which was ...
Breaking Biology News(10 mins):Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 2Wocket Smart Wallet Commercials Airing on CNBC to Showcase This Summer's Must- Have Tech Product 3HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 2HYPR Corp. Expands Biometric Authentication Team with Enterprise All Stars 3
... In a medical case of Jekyll and Hyde, carbon ... and faulty heating systems ?has proven effective in treating ... debilitating condition that typically leads to right heart failure ... an animal study led by researchers at Beth Israel ...
... researchers at Washington University School of Medicine in St. ... Studying rotator cuff injury in rats, the research team ... could cause failure of rotator cuff repair following surgery ... host of physical problems, from cardiovascular disease to lung ...
... the Quirón Hospital in Donostia-San Sebastián has managed, for the ... an embryonic sex selection in a woman who is a ... chromosome ?in order to avoid giving birth to a male ... eyes of a degenerative nature. It causes a serious reduction ...
Cached Biology News:Therapeutic role found for carbon monoxide 2Therapeutic role found for carbon monoxide 3Cigarette smoking impedes tendon-to-bone healing 2Cigarette smoking impedes tendon-to-bone healing 3
Mouse monoclonal [2G1] to Vancomycin ( Abpromise for all tested applications)....
Rat polyclonal to acetyl Salicylic Acid ( Abpromise for all tested applications)....
Request Info...
... Quality 96 Well BAC Prep; ... preparation from 1.5ml 2xYT cultures; ... automated fluorescent sequencing for small ... ProPrep strategy which minimizes shearing ...
Biology Products: